Skip to main content
Veterinary Medicines

Narkamon 100 mg/ml Roztwór do wstrzykiwań

Authorised
This information is not available for this product.

Product identification

Medicine name:
Narkamon 100 mg/ml Roztwór do wstrzykiwań
Active substance:
This information is not available for this product.
Target species:
  • Dog
  • Horse
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
This information is not available for this product.
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
      • All relevant tissues
        no withdrawal period
    • Horse
    • Cat
      • All relevant tissues
        no withdrawal period
  • Intravenous use
    • Dog
      • All relevant tissues
        no withdrawal period
    • Horse
    • Cat
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01AX03
Authorisation status:
  • Valid
Authorised in:
  • Poland
Available in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Grabikowski-Grabikowska Przedsiebiorstwo Produkcyjno-Handlowo-Uslugowe Inex Sp. j.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 2556
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."